Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03239665 · ClinicalTrials.gov registry record · NA
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 335
- Enrollment target
NCT03239665 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 335 participants.
The verdict
NCT03239665, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 335 participants
- Enrollment target
Study Summary
The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will consist of a 60-minute presentation about the three vaccine-preventable diseases and their vaccinations delivered by a pharmacist, featuring a didactic lecture and discussion supplemented by video clips of community members discussing their experiences around vaccination, as well as physicians underscoring the importance of vaccination. PEER will consist of a 60-minute small-group session led by a peer educator which includes scripted roleplaying exercises designed to reinforce learnings pertaining to these three vaccine-preventable diseases and their vaccinations. The components of these interventions will be designed to address specific barriers to vaccination identified by literature search and our prior work in the area of community-based vaccine education. Both arms will focus primarily on pneumococcal disease and zoster but will include limited content on influenza because participants are likely to have questions about how the flu and its vaccination differ from pneumococcal diseases and zoster. The study will be implemented in an older, predominantly African-American (AA) population, consistent with our prior work in this area.
Interventions
- BEHAVIORAL Pharmacist-led Intervention (PHARM)
- BEHAVIORAL Peer-led Intervention (PEER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03239665
The ClinicalTrials.gov registry entry for NCT03239665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharmacist-led Intervention (PHARM) is the first listed.
NCT03239665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03239665 about?
NCT03239665 is a clinical study titled "Vaccination Education Through Pharmacists and Senior Centers (VEPSC)". The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will consist of a 60-minute presentation about the three vaccine-preventable diseases and their vaccinations delivered b...
What is the current status of trial NCT03239665?
This trial is currently completed. It is a NA study. The enrollment target is 335 participants. The study started on 2017-10-10. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03239665?
The interventions under investigation include: Pharmacist-led Intervention (PHARM) (BEHAVIORAL), Peer-led Intervention (PEER) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03239665?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.